reported that the BNT162b2 mRNA vaccine elicits CD8+ T cells in infection-naïve individuals, primarily with an effector memory phenotype (approximately 80% of the specific CD8+ T cells), some central memory T cells, and a few cells with a Tscm phenotype.15 Here, CD8A is linked to infection.